Published in Kidney Int on June 13, 2007
Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance | NCT01545531
Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis | NCT04034966
Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation | NCT04842591
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health (2008) 4.49
Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol (2009) 4.31
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One (2010) 3.64
Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54
Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med (2013) 2.28
White/black racial differences in risk of end-stage renal disease and death. Am J Med (2009) 2.16
Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Kidney Int (2012) 1.92
Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol (2011) 1.89
The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol (2013) 1.87
Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension (2010) 1.81
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81
Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes (2009) 1.78
Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76
Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study. Nephrol Dial Transplant (2011) 1.74
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet (2011) 1.68
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
Advances in glomerular filtration rate-estimating equations. Curr Opin Nephrol Hypertens (2010) 1.49
Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis (2010) 1.42
Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes (2012) 1.38
Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol (2012) 1.37
High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol (2009) 1.29
Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis (2013) 1.24
Albumin testing in urine using a smart-phone. Lab Chip (2013) 1.23
Uric acid as a target of therapy in CKD. Am J Kidney Dis (2012) 1.22
High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health (2009) 1.21
CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol (2012) 1.20
Prevalence and incidence of chronic kidney disease stage G5 in Japan. Clin Exp Nephrol (2014) 1.20
Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol (2014) 1.19
Chronic kidney disease and cancer: a troubling connection. J Nephrol (2010) 1.18
Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis (2011) 1.15
Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP). Clin J Am Soc Nephrol (2011) 1.13
Acoustic radiation force impulse imaging for noninvasive evaluation of renal parenchyma elasticity: preliminary findings. PLoS One (2013) 1.13
Klotho and chronic kidney disease. Contrib Nephrol (2013) 1.11
Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J Am Soc Nephrol (2008) 1.09
Public health surveillance of CKD: principles, steps, and challenges. Am J Kidney Dis (2009) 1.08
Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrol (2013) 1.07
Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study. Clin Exp Nephrol (2010) 1.07
UMOD as a susceptibility gene for end-stage renal disease. BMC Med Genet (2012) 1.06
Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides. J Am Soc Nephrol (2015) 1.05
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med (2015) 1.03
Renal stem cells: fact or science fiction? Biochem J (2012) 1.02
Validation of a case definition to define chronic dialysis using outpatient administrative data. BMC Med Res Methodol (2011) 1.01
High burden and unmet patient needs in chronic kidney disease. Int J Nephrol Renovasc Dis (2012) 1.00
Uranium associations with kidney outcomes vary by urine concentration adjustment method. J Expo Sci Environ Epidemiol (2013) 0.98
Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Curr Diab Rep (2011) 0.98
Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant (2011) 0.97
Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries. Clin Exp Nephrol (2009) 0.97
The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis. Kidney Int (2014) 0.97
Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol (2014) 0.96
TGF-β signaling via TAK1 pathway: role in kidney fibrosis. Semin Nephrol (2012) 0.96
Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2011) 0.96
Arsenic and Chronic Kidney Disease: A Systematic Review. Curr Environ Health Rep (2014) 0.96
Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol (2011) 0.95
Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort. Heart Vessels (2016) 0.95
Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant (2010) 0.95
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol (2015) 0.94
Nephrology in Africa--not yet uhuru. Nat Rev Nephrol (2013) 0.94
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant (2015) 0.94
Racial disparities in kidney disease outcomes. Semin Nephrol (2013) 0.93
Measuring the quality of provided services for patients with chronic kidney disease. Nephrourol Mon (2014) 0.93
Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis. Am J Hypertens (2013) 0.93
Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol (2013) 0.93
A risk score for chronic kidney disease in the general population. Am J Med (2012) 0.93
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade. Kidney Int (2014) 0.93
Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism (2013) 0.92
Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis. PLoS One (2014) 0.90
Kidney disease: improving global outcomes. Nat Rev Nephrol (2009) 0.90
Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists. BMC Public Health (2013) 0.90
Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy. Adv Ther (2015) 0.90
Pulse pressure and presence of coronary artery calcification. Clin J Am Soc Nephrol (2009) 0.89
Prevalence and Correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol (2015) 0.89
Barriers to successful implementation of care in home haemodialysis (BASIC-HHD):1. Study design, methods and rationale. BMC Nephrol (2013) 0.89
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort. J Am Soc Nephrol (2014) 0.89
Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. Nephrol Dial Transplant (2009) 0.89
Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Sci Rep (2015) 0.88
Surface glycosylation profiles of urine extracellular vesicles. PLoS One (2013) 0.88
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney Int (2014) 0.88
Therapeutic targets for treating fibrotic kidney diseases. Transl Res (2014) 0.88
Population-based screening for CKD. Am J Kidney Dis (2009) 0.88
Global proteinuria guidelines: are we nearly there yet? Clin Biochem Rev (2011) 0.87
Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study. BMC Nephrol (2015) 0.86
Mid-adulthood risk factor profiles for CKD. J Am Soc Nephrol (2014) 0.86
Metabolic syndrome and chronic kidney disease in an adult Korean population: results from the Korean National Health Screening. PLoS One (2014) 0.86
Factors associated with CKD in the elderly and nonelderly population. Clin J Am Soc Nephrol (2012) 0.86
Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis. Am J Physiol Renal Physiol (2014) 0.86
Effect of chronic kidney disease on the healing of titanium implants. Bone (2013) 0.85
Comparisons between the 2012 new CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and other four approved equations. PLoS One (2014) 0.85
Vitamin D supplementation enhances the fixation of titanium implants in chronic kidney disease mice. PLoS One (2014) 0.85
Multicenter study of creatinine- and/or cystatin C-based equations for estimation of glomerular filtration rates in Chinese patients with chronic kidney disease. PLoS One (2013) 0.85
Prevalence of chronic kidney disease and its association with metabolic diseases: a cross-sectional survey in Zhejiang province, Eastern China. BMC Nephrol (2014) 0.85
Design of a new therapy for patients with chronic kidney disease: use of microarrays for selective hemoadsorption of uremic wastes and toxins to improve homeostasis. Drug Des Devel Ther (2015) 0.85
Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Trials (2015) 0.85
Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease. BMC Nephrol (2012) 0.84
Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA (1999) 40.60
Fatigue, retention of action current and recovery in crustacean nerve. J Physiol (1927) 18.06
Race, gender, and partnership in the patient-physician relationship. JAMA (1999) 13.80
The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med (1999) 7.68
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet (1993) 6.56
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2006) 5.69
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med (1999) 5.27
The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med (1999) 5.04
The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg (1998) 4.46
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Rhabdomyolysis. J Am Soc Nephrol (2000) 4.14
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation (2000) 4.06
Quantitation of thermography in arthritis using multi-isothermal analysis. I. The thermographic index. Ann Rheum Dis (1974) 3.82
Costs vs quality in different types of primary care settings. JAMA (1994) 3.81
Identification of patient attitudes and preferences regarding treatment of depression. J Gen Intern Med (1997) 3.77
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med (1998) 3.59
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol (1999) 3.36
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int (2006) 3.36
The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA (1991) 3.29
Copper staining: a five-minute protein stain for sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem (1987) 3.28
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol (2000) 3.27
Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol (1996) 3.24
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int (2000) 2.85
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int (2000) 2.80
Early hospital readmission after kidney transplantation: patient and center-level associations. Am J Transplant (2012) 2.78
Axis I comorbidity of borderline personality disorder. Am J Psychiatry (1998) 2.71
Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evid Rep Technol Assess (Summ) (2005) 2.69
Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry (1997) 2.67
Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc (1998) 2.54
Barriers pediatricians face when using asthma practice guidelines. Arch Pediatr Adolesc Med (2000) 2.49
Mental health service utilization by African Americans and Whites: the Baltimore Epidemiologic Catchment Area Follow-Up. Med Care (1999) 2.45
Long-term outcomes in nondiabetic chronic kidney disease. Kidney Int (2008) 2.41
Elevated levels of serum creatinine: recommendations for management and referral. CMAJ (1999) 2.40
Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant (2005) 2.40
Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis (1999) 2.38
Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol (2001) 2.35
Race and sex differences in the distribution of cerebral atherosclerosis. Stroke (1996) 2.35
Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost (2006) 2.35
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA (1996) 2.30
Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol (1994) 2.28
Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am J Epidemiol (1994) 2.28
Obstacles to residents' conducting research and predictors of publication. Acad Med (2001) 2.25
Should euthanasia be legal? An international survey of neonatal intensive care units staff. Arch Dis Child Fetal Neonatal Ed (2004) 2.21
Treatment choices for extremely preterm infants: an international perspective. J Pediatr (2000) 2.19
Temperature and biochemical studies of joint inflammation. A preliminary investigation. Ann Rheum Dis (1970) 2.15
Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int (2006) 2.07
The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion (2002) 2.06
Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis (2001) 2.05
Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis (1999) 2.05
Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol (1999) 2.04
Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy. JAMA (2000) 2.04
Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia (2011) 2.03
False positives and negatives in routine testing for drugs of abuse. Lancet (1995) 2.02
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med (2001) 1.97
An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2001) 1.90
Mutation analysis of 3 genes in patients with Leber congenital amaurosis. Arch Ophthalmol (2000) 1.89
Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl (2006) 1.88
Isolation, characterisation and mapping of simple sequence repeat loci in potato. Mol Gen Genet (1998) 1.88
Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc (2000) 1.83
Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int (2006) 1.80
Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet (1986) 1.80
Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2006) 1.79
How important is intrinsic spirituality in depression care? A comparison of white and African-American primary care patients. J Gen Intern Med (2001) 1.77
Estimates of costs of primary care physician turnover. Am J Manag Care (1999) 1.76
Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology (2011) 1.76
Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry (2009) 1.74
Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab (2000) 1.73
A new Mother-to-Infant Bonding Scale: links with early maternal mood. Arch Womens Ment Health (2005) 1.71
Use of cardiovascular procedures among black persons and white persons: a 7-year nationwide study in patients with renal disease. Ann Intern Med (1999) 1.68
Autologous blood transfusion in the United States: clinical and nonclinical determinants of use. Transfusion (2001) 1.68
Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys (1994) 1.68
Quantitative thermography. Rheumatol Phys Med (1970) 1.67
US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis (2000) 1.65
A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med (1999) 1.65
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis (2001) 1.64
Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report. Clin Nephrol (2011) 1.64
Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"? Am J Kidney Dis (2001) 1.61
Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials (2000) 1.60
Primary care patients' opinions regarding the importance of various aspects of care for depression. Gen Hosp Psychiatry (2000) 1.60
Racial differences in access to the kidney transplant waiting list for children and adolescents with end-stage renal disease. Pediatrics (2000) 1.60
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis (2001) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis (2000) 1.55
Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol (1998) 1.54
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int (2007) 1.53